F
First Choice Neurology | Neurology Office of South Florida
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Ofatumumab
SAR441344
Frexalimab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 4 total trials
The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the dis...
Enrolling
Multiple Sclerosis
Drug: Frexalimab
Drug: Placebo
This study will evaluate the pharmacokinetics, pharmacodynamics, safety and tolerability of a new dosage of ofatumumab compared to the approved dosag...
Active, not recruiting
Relapsing Multiple Sclerosis (RMS)
Biological: Ofatumumab approved dose
Biological: Ofatumumab new dose
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems